Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
New York, NY
SEC filing record 1 source field available
Fiscal year end
31 December
BRAINSTORM CELL THERAPEUTICS INC. has filed 949 SEC EDGAR filings since 24 May 2001

SEC filing history

Showing 626-650 of 725 matching filings.

Per page
25
Current page
26
S-1/A File 333-179331

FORM S-1/A

Filing date
22 Mar 2012
Reporting date
Not listed
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
19 Mar 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54365

FORM 8-K

Filing date
13 Mar 2012
Reporting date
12 Mar 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
27 Feb 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
14 Feb 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1 File 333-179331

FORM S-1

Filing date
03 Feb 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54365

FORM 8-K

Filing date
18 Jan 2012
Reporting date
17 Jan 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
12 Jan 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K/A File 000-54365

FORM 10-K/A

Filing date
28 Dec 2011
Reporting date
31 Dec 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
21 Dec 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
07 Dec 2011
Reporting date
05 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
30 Nov 2011
Reporting date
28 Nov 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 000-54365

FORM 8-K/A

Filing date
16 Nov 2011
Reporting date
22 Aug 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

OWNERSHIP DOCUMENT

Filing date
16 Nov 2011
Reporting date
21 Oct 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
09 Nov 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
26 Oct 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
06 Oct 2011
Reporting date
04 Oct 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q/A File 000-54365

EXHIBIT 10-Q/A

Filing date
07 Sep 2011
Reporting date
30 Jun 2011
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
23 Aug 2011
Reporting date
22 Aug 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
23 Aug 2011
Reporting date
22 Aug 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54365

FORM 8-K

Filing date
23 Aug 2011
Reporting date
22 Aug 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
16 Aug 2011
Reporting date
10 Aug 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-54365

FORM 10-Q

Filing date
15 Aug 2011
Reporting date
30 Jun 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .